【摘要】：目的：本研究旨在編制出一個適合中國人群的苯丙胺戒斷后癥狀評定量表,并對其進行心理測量學檢驗。 方法：在湖南省各戒毒所對符合入組條件的苯丙胺依賴者進行資料收集,通過查閱文獻、開放性訪談并結(jié)合戒毒所專家臨床經(jīng)驗初步確定苯丙胺戒斷后癥狀評定量表的條目庫,對量表進行小樣本預試(n=20),確定量表初稿。量表正式施測后(n=200),通過項目分析和探索性因素分析,按相關標準刪除不符合的條目,形成量表的初步理論框架,并對量表進行心理測量學檢驗,選用分半信度、Cronbach's Alpha系數(shù)和Kendall和諧系數(shù)檢驗量表的信度,選用內(nèi)容效度、專家效度、結(jié)構(gòu)效度和校標效度檢驗量表的效度。 結(jié)果：(1)通過項目分析和篩選,確定量表由20個條目組成,探索性因素分析確定量表共包含4個因素,解釋總變異的54.895%,4個因素分別命名為：F1：渴求、F2：情緒障礙、F3：軀體癥狀和F4：精神病性癥狀。(2)內(nèi)部一致性分析顯示：全量表和各因素分半信度系數(shù)分別為：0.883、0.807、0.829、0.796、0.718�？偭勘砗透饕蜃拥膬�(nèi)部一致性信度Cronbach's Alpha系數(shù)為0.846,0.807、0.811、0.793、0.759,量表他評部分Kendall W系數(shù)為0.682,P值為0.0310.05。(3)量表內(nèi)部相關分析顯示：各條目與量表總分之間的相關系數(shù)在0.380-0.641之間,各因素與總量表總分之間相關系數(shù)在0.488-0.762之間；各因素間相關系數(shù)為0.166-0.409,相關均具有顯著性(p0.01)。(4)量表總分與CGI、HAMD、HAMA和PANSS得分均有顯著的正相關(p0.01),相關系數(shù)在0.464-0.657之間,且各分量表與相似內(nèi)容的量表相關度較高,精神病性癥狀和PANSS相關系數(shù)最高(r=0.547),情緒障礙因子與HAMD和HAMA得分相關系數(shù)最高,分別為0.625和0.466。(5)量表及其各因子與停用前一月冰毒使用天數(shù)和總使用量均有顯著的正相關(p0.01),且使用量差異研究結(jié)果顯示,受試者中高使用量組總量表和各因子得分均顯著高于低使用組,差異均具有顯著性(p0.01)。 結(jié)論：(1)本研究初步完成了苯丙胺戒斷后癥狀評定量表的編制工作,經(jīng)過探索性因素分析初步構(gòu)建出該量表的合理結(jié)構(gòu)。(2)信度研究表明,該量表的內(nèi)部一致性信度較好,達到了心理測量學的要求。(3)內(nèi)容效度和專家效度分析表明,該量表具有較好的內(nèi)容效度和專家效度。(4)量表的內(nèi)部一致性和因素分析發(fā)現(xiàn),該量表具有較好的結(jié)構(gòu)效度。(5)量表與CGI、HAMD、HAMA和PANSS4個量表的相關結(jié)果表明,該量表具有較好的校標效度；量表與停用前一月冰毒使用天數(shù)和總使用量的相關結(jié)果表明,該量表具有較好的實證效度；苯丙胺高低使用組的差異分析也表明,該量表具有較高的實證效度。
[Abstract]:Objective: to develop a scale for assessing the symptoms of amphetamine withdrawal in Chinese population and to test it with psychometrics. Methods: the data of amphetamine-dependent patients who met the condition of admission were collected in the rehabilitation centers of Hunan Province. By consulting literature, opening interviews and combining with clinical experience of experts in rehabilitation centers, the item library of the assessment scale for symptoms after withdrawal of amphetamine was preliminarily determined. Small sample pre-test (nn-20) was performed to determine the first draft of the scale. After the formal implementation of the scale (nnm200), item analysis and exploratory factor analysis were used to delete the non-conforming items according to the relevant criteria, to form the preliminary theoretical framework of the scale, and to conduct psychometric tests on the scale, and to select the split-half reliability. Cronbach's Alpha coefficient and Kendall harmony coefficient were used to test the reliability of the scale, content validity, expert validity, structural validity and calibration validity were used to test the validity of the scale. Results: (1) by item analysis and screening, the scale was composed of 20 items, and exploratory factor analysis showed that the scale consisted of 4 factors, 54.895of which explained the total variation, and the four factors were named F1: craving, respectively. F2: emotional disorder, F3: somatic symptom and F4: psychotic symptom. (2) Internal consistency analysis showed that the whole scale and the factor split-half reliability coefficient were 0.8830.8070.8070.7960.796and 0.718 respectively. The Cronbach's Alpha coefficient of internal consistency reliability of total scale and each factor was 0.846 / 0.807 / 0.8110.793/ 0.759, and the Kendall W coefficient of the other part of the scale was 0.682and 0.682respectively. P value was 0.0310.05. (3) the correlation coefficient between each item and the total score was 0.380-0.641, and the correlation coefficient between each factor and the total score was 0.488-0.762; The correlation coefficient between each factor was 0.166-0.409. There was significant positive correlation between the total score of CGI,HAMD,HAMA and PANSS and the total score of CGI,HAMD,HAMA and PANSS (p0.01). (4), the correlation coefficient was 0.464-0.657, and the correlation coefficient was 0.464-0.657. The correlation between each subscale and similar scale was higher, the correlation coefficient between psychotic symptoms and PANSS was the highest (r = 0.547), and the correlation coefficient between emotional disorder factor and HAMD and HAMA scores was the highest. (5) the scale and its factors were positively correlated with the days of meth use and the total usage of methamphetamine in the month before cessation (p0.01). The scores of total amount and factors in the high usage group were significantly higher than those in the low use group (p0.01). Conclusion: (1) this study has preliminarily completed the development of the rating scale for symptoms after withdrawal of amphetamine, and has preliminarily constructed the reasonable structure of the scale by exploratory factor analysis. (2) the reliability study shows that, The internal consistency reliability of the scale is good, which meets the requirements of psychometrics. (3) the analysis of content validity and expert validity shows that, (4) the internal consistency and factor analysis of the scale showed that the scale had good structural validity. (5) the correlation between the scale and CGI,HAMD,HAMA and PANSS4 scales showed that the scale had good structural validity. The scale has good calibration validity. The results of correlation between the scale and the days of meth use and the total usage of methamphetamine before discontinuation showed that the scale had a good empirical validity, and the difference analysis of the high and low use groups of amphetamine also showed that the scale had a high empirical validity.
【學位授予單位】：中南大學
【學位級別】：碩士
【學位授予年份】：2013
【分類號】：R749.64

【參考文獻】

相關期刊論文 前3條

1 湯毓華;張明園;;漢密頓抑郁量表(HAMD)[J];上海精神醫(yī)學;1984年02期

2 諶紅獻,郝偉,楊德森;阿片類稽延性戒斷癥狀自評量表的初步編制[J];中國心理衛(wèi)生雜志;2003年05期

3 司天梅,楊建中,舒良,王希林,孔慶梅,周沫,李雪霓,劉粹;陽性和陰性癥狀量表(PANSS,中文版)的信、效度研究[J];中國心理衛(wèi)生雜志;2004年01期

，

本文編號：2420413